PMDA drug package insert
タルグレチンカプセル75mg
PMDA Prescription drug · 株式会社ミノファーゲン製薬 · package insert Jun 24, 2024
Key facts
| Brand names | タルグレチンカプセル75mg |
|---|---|
| Nonproprietary names | ベキサロテン |
| Companies | 製造販売元／株式会社ミノファーゲン製薬 |
| Product type | Prescription drug |
| Therapeutic category | 抗悪性腫瘍剤 |
| Therapeutic category codes | 874291 |
| YJ codes | 4291042M1022 |
| Approval numbers | 22800AMX00025000 |
| Package insert edition | 第2版 |
| Package insert date | Jun 24, 2024 |
| PMDA document key | 750315_4291042M1022_1 |
| PMDA company code | 750315 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- None Safety communications
- Yes PMDA review report published
- Yes Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: